Insulin

Massive $452 Million Win for Insulet Corp in Trade Secrets Lawsuit Against Competitive Insulin Patch Maker

by

Boston — In a landmark decision on Tuesday, a Massachusetts federal jury awarded Insulet Corporation a staggering $452 million in damages over trade secret misappropriation by a competing firm, marking a major victory in corporate intellectual property rights litigation. Insulet Corporation, based in Massachusetts, has been a pioneer in the development of tubeless insulin pump patches market with its Omnipod products since receiving FDA approval in 2005. The defendant, identified as a direct competitor, also manufactures insulin pump patches and introduced its original product line in 2011, with an advanced version hitting the market in … Read more

Massachusetts Firm Wins Record $452 Million in Trade Secrets Case Over Insulin Pump Technology

by

In a landmark case, a Massachusetts court awarded the Insulet Corporation a staggering $452 million in what is considered the largest jury verdict ever under the federal Defend Trade Secrets Act (DTSA). This case underscores a growing trend toward substantial financial awards in trade secret litigation. Insulet Corporation, based in Massachusetts, initiated the lawsuit after discovering that its former employees, who had joined South Korean firm EOFlow, allegedly transferred confidential information critical to their proprietary insulin pump, the OmniPod. EOFlow utilized this information to develop similar technology, debuting their EOPatch and EOPatch 2 insulin pumps … Read more

Insulet Wins Massive $452 Million in Trade Secret Lawsuit Against EOFlow Over Insulin Device Innovations

by

BOSTON — In a landmark legal decision, Insulet Corp., headquartered in Massachusetts, triumphed in a major trade secrets lawsuit against South Korea-based EOFlow Co. Ltd., with a federal jury awarding the U.S. medical device maker a colossal $452 million. The verdict, reached on Tuesday, marks a significant moment in the realm of intellectual property rights within the highly competitive medical device industry. Insulet Corp. has been developing its innovative OmniPod insulin pump since the early 2000s, a device that has significantly impacted the management of diabetes through its advanced, wearable technology. The lawsuit emerged following … Read more

Pharmacy Benefit Managers and Drug Companies Face Lawsuit for Inflating Insulin Prices, Targeting Vulnerable Patients in Indiana

by

Indianapolis, Indiana – The Attorney General of Indiana, Todd Rokita, has filed a lawsuit alleging that pharmacy benefit managers (PBMs) and drug companies have colluded to maintain high insulin prices. Rokita claims that these companies are exploiting vulnerable individuals in need of this vital medication. The lawsuit does not specifically name the drug company Eli Lilly, even though it settled a class-action lawsuit last year over allegations of insulin price fixing for over $13 million. Among the companies named in the lawsuit are Caremark PCS and CVS Healthcorp, both associated with CVS, one of the … Read more